Antonio Llombart
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.
Journal: ESMO open
Published: April 11, 2026
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Navigating first- and second-line treatment options in HR+HER2-negative advanced breast cancer.
Journal: The oncologist
Published: January 22, 2026
Correction: Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.
Journal: Targeted oncology
Published: March 10, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2025
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.
Journal: Targeted oncology
Published: December 21, 2024
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper".
Journal: Breast (Edinburgh, Scotland)
Published: March 03, 2024
Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity.
Journal: Annals of translational medicine
Published: May 09, 2023
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
Journal: European journal of clinical nutrition
Published: May 10, 2021
Last Updated: 09/26/2026